ReviewFrontiers in pharmacology2024

Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.